Non-communicable diseases (NCDs) thrive on oxidative stress, an imbalance of reactive oxygen species. This review delves into the crucial interplay between antioxidant enzymes and dietary antioxidants.
Sabih Chaudhry, CEO of Afon Technology Ltd, describes the company’s innovative Glucowear™ — the world’s first non-invasive, real-time, and continuous blood glucose sensor.
Cardiovascular disease (CVD) is the leading cause of death in women worldwide, highlighting the need for greater awareness and research into sex and gender differences impacting cardiovascular care.
Neurological diseases are the foremost cause of ill health and disability worldwide. Open Access Government offers an overview of the prevalence of these conditions.
In June, Alzheimer's and brain awareness month, Mayo Clinic researchers have identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease.
Researchers at Queen Mary University of London have made a significant breakthrough in the early prediction of dementia, developing a new method that can predict the disease with over 80% accuracy up to nine years before a clinical diagnosis.
Researchers have found a new method to distinguish between Dementia with Lewy Bodies (DLB) and Alzheimer's Disease (AD) using vocal emotional expressions.
Michael Wong, JD, Executive Director at the Physician-Patient Alliance for Health & Safety, posits a combination of quantitative and qualitative assessments of the patient as key measures for tackling sepsis.
There are about 36 million individuals in the EU living with a rare disease. Sandra Gallina, Director General at DG Sante, explains how the European Commission is addressing the needs of this community.
Asal Shirazi, Founder and CEO of the Autoimmune Support and Awareness (ASA) Foundation, explains the challenges in detecting, diagnosing and managing autoimmune conditions.
An HIV vaccine candidate developed at the Duke Human Vaccine Institute has demonstrated the ability to trigger low levels of a rare type of neutralising antibodies (bnAbs) in a small group of participants.
A recent study led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona...
As the population ages, the economic toll of dementia on the UK is projected to skyrocket, reaching £91 billion a year by 2040, according to a study conducted for the Alzheimer’s Society.
Researchers have found evidence suggesting that lifestyle factors may play a pivotal role in mitigating the risk of Alzheimer's disease, even among individuals carrying the ApoE4 gene variant.
